April 2014
Volume 55, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2014
Tumor Necrosis Factor Alpha and Leptin Levels in Boston Keratoprosthesis Patients: Preliminary Data
Author Affiliations & Notes
  • Eleftherios I Paschalis
    Ophthalmology - Cornea Service, Massachusetts Eye and Ear Infirmary - Harvard Medical School, Boston, MA
  • Elise Taniguchi
    Ophthalmology - Cornea Service, Massachusetts Eye and Ear Infirmary - Harvard Medical School, Boston, MA
  • Alja Crnej
    Ophthalmology - Cornea Service, Massachusetts Eye and Ear Infirmary - Harvard Medical School, Boston, MA
  • Kathryn Colby
    Ophthalmology - Cornea Service, Massachusetts Eye and Ear Infirmary - Harvard Medical School, Boston, MA
  • Louis R Pasquale
    Ophthalmology - Glaucoma Service, Massachusetts Eye and Ear Infirmary - Harvard Medical School, Boston, MA
  • James Chodosh
    Ophthalmology - Cornea Service, Massachusetts Eye and Ear Infirmary - Harvard Medical School, Boston, MA
  • Claes H Dohlman
    Ophthalmology - Cornea Service, Massachusetts Eye and Ear Infirmary - Harvard Medical School, Boston, MA
  • Lucy Q Shen
    Ophthalmology - Glaucoma Service, Massachusetts Eye and Ear Infirmary - Harvard Medical School, Boston, MA
  • Footnotes
    Commercial Relationships Eleftherios Paschalis, None; Elise Taniguchi, None; Alja Crnej, None; Kathryn Colby, None; Louis Pasquale, None; James Chodosh, None; Claes Dohlman, None; Lucy Shen, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science April 2014, Vol.55, 3735. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Eleftherios I Paschalis, Elise Taniguchi, Alja Crnej, Kathryn Colby, Louis R Pasquale, James Chodosh, Claes H Dohlman, Lucy Q Shen, ; Tumor Necrosis Factor Alpha and Leptin Levels in Boston Keratoprosthesis Patients: Preliminary Data. Invest. Ophthalmol. Vis. Sci. 2014;55(13):3735.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: Tumor necrosis factor alpha (TNF-α) is a pluripotent cytokine, which is up-regulated during wound healing and can mediate retinal ganglion cell (RGC) apoptosis and glaucoma. Recent reports suggest that Boston Keratoprosthesis (BKpro) patients are more likely to develop glaucomatous optic nerve damage, even with normal intraocular pressure (IOP). We hypothesize that the persistent corneal wound healing in BKpro subjects potentiates the up-regulation of TNF-α, which may explain the high prevalence of glaucoma in these patients. This study evaluated the levels of soluble TNF-α (sTNF-α), sTNFR-I and II receptors, and leptin, a neurotrophic factor, in the blood of patients with and without BKpro.

Methods: Venous blood of BKpro (n=7) and non-BKpro (n=9) patients was collected in the morning hours using EDTA tubes. sTNF-α, sTNFRs and leptin plasma levels were quantified using the enzyme-linked immunosorbent assay (ELISA). Other tests performed included: erythrocyte sedimentation rate (ESR), body mass index (BMI) and IOP. Patients with underlying inflammatory conditions were excluded from this study.

Results: Median ± standard error of means for age (59±3.7 years), BMI (25±1.5), IOP (15±1 mmHg) and ESR (9±1.8mm/hr) were similar among the groups (p>0.07; Mann-Whitney test). Likewise, sTNF-α (1.4±0.2 ng/mL), sTNFR-I (911±55 ng/mL), sTNFR-II (2433±191 ng/mL) and leptin (18.463±5.679 pg/mL) levels were not statistically different (p>0.11) among the groups; however, the sTNF-α/sTNFR-I ratio was significantly higher in the BKpro group (0.0022) compared to the non-BKpro (0.0013; p=0.04).

Conclusions: In this preliminary study, sTNF-α to sTNFR-I ratio was elevated in BKpro patients. This elevation can be attributed to the persistent, subclinical, corneal wound healing, measurable in the blood plasma. The increase in ratio can result in inadequate inhibition of sTNF-α, and detrimental effects on retinal ganglion cells. Further evaluation of a larger sample size, with sub-classification of glaucoma patients, is currently underway.

Keywords: 575 keratoprostheses • 610 nerve fiber layer • 464 clinical (human) or epidemiologic studies: risk factor assessment  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×